Understanding AARS2-Related Ovarioleukodystrophy

Receiving a diagnosis of AARS2-related leukoencephalopathy with ovarian failure (often shortened to ALO or AARS2-related ovarioleukodystrophy) can feel overwhelming, especially because the name itself is a mouthful and the condition is so rare that most people—including many doctors—have never heard of it ^[1]. This diagnosis often follows a “diagnostic odyssey,” a long period of searching for answers while symptoms are misattributed to more common conditions like early-onset dementia, psychiatric disorders, or primary ovarian insufficiency ^[1][2].

What is AARS2-Related Disease?

AARS2-related disease is a rare genetic condition that primarily affects the white matter of the brain (the “insulation” that helps nerve signals travel) and the function of the ovaries ^[1][3]. It is caused by mutations in the AARS2 gene, which provides instructions for an enzyme essential to the mitochondria—the powerhouses of your cells ^[3][4].

When these powerhouses don’t work correctly in the brain and ovaries, it leads to two main hallmarks:

• Leukoencephalopathy: “Leuko” means white, “encephalo” means brain, and “pathy” means disease. This refers to the progressive loss or damage of white matter ^[1].
• Ovarian Failure: Also called premature ovarian insufficiency (POI), this means the ovaries stop functioning earlier than expected, often before age 40, which affects fertility and hormone levels ^[1][5].
• Cardiomyopathy: Importantly, the broader AARS2 spectrum can also include heart muscle disease, particularly in early-onset cases, so cardiac evaluation may be recommended. Note that neurological disease can also occur in males and in females without POI.

Understanding the Rarity

This condition is exceptionally rare. A major review published in 2024 identified only 71 genetically confirmed cases reported in the medical literature ^[1]. Because it is so rare, your local doctor or even a general neurologist may not have encountered it before. This is not a reflection of their skill, but rather the reality of “orphan diseases” that are only recently being understood through advanced genetic testing ^[1][2].

When Does it Start and How Does it Progress?

AARS2-related disease is highly variable, meaning it looks different for every person.

• Age of Onset: Among reported cases, the average age when symptoms first appear is roughly 27 years old, but the range is very broad—from birth up to age 57 ^[1]. About 22.5% of cases begin in childhood ^[1].
• Initial Symptoms: Many people first notice subtle cognitive changes (difficulty with memory or planning) or psychiatric symptoms (changes in mood or behavior) ^[1].
• Physical Changes: Over time, it may affect movement, leading to ataxia (clumsiness or lack of coordination), pyramidal signs (stiffness or weakness in the limbs), or a changed walking pattern (gait disturbance) ^[1].
• Progression: The speed of change varies significantly. Some individuals remain functionally stable for many years, while others may experience periods of more rapid decline in their ability to perform daily activities ^[6][7].

Why the Ovaries are Involved

Among reported cases with available information, about 82% of females with this condition had the ovaries affected ^[1]. This may show up as primary amenorrhea (never starting a menstrual period) or as periods that stop very early in adulthood ^[1]. Because the AARS2 gene is vital for mitochondrial function, and the developing eggs and ovarian tissues are highly dependent on energy, they are uniquely vulnerable to these genetic mutations ^[3][5].

Common Misunderstandings

• “It’s only an ovarian issue”: Some patients are first diagnosed with premature menopause and don’t realize the neurological symptoms are connected until years later ^[1].
• “It’s always a rapid decline”: While it is a progressive condition, the rate varies. Some people maintain independence for decades ^[6].
• “MRI tells the whole story”: While a brain MRI often shows characteristic patterns (like rarefaction, where the white matter looks “thin” or “holey” on specific scans), some people have significant symptoms before the MRI shows clear changes. MRI is supportive, not absolute ^[1][8][9].

Managing the Diagnosis

Because there is currently no cure, care focuses on managing symptoms and improving quality of life. This typically involves a “care team” approach:

1. Neurology: To monitor brain health and manage symptoms like stiffness or seizures ^[10].
2. Endocrinology/Gynecology: To discuss Hormone Replacement Therapy (HRT), which can help manage the symptoms of low estrogen and protect bone and heart health ^[11][5].
3. Genetics: To help you and your family understand the inheritance pattern (it is autosomal recessive, meaning a person usually inherits one mutated gene from each parent) ^[1].
4. Cardiology: For periodic cardiac assessments.
5. Support: Connecting with rare disease communities can help validate the complex emotions—grief, confusion, and sometimes relief at finally having a name for what is happening.